Matthew Blatnik
Matthew Blatnik has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Anna Gao
Pfizer, Inc
1 shared publicationAnu Nigam
Internal Medicine Research Unit, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA
1 shared publicationArthur Bergman
Clinical Pharmacology, Pfizer Worldwide Research, Development, and Medical, Cambridge, MA 02139 USA
1 shared publication- Bhavna Adhin
Pfizer, Inc
1 shared publication - Brendan Tierney
Pfizer Inc
1 shared publication Briana Peterson
Pfizer, Inc
1 shared publication
Latest Publications
- Open Access
- 3 June 2025
- Published by Taylor & Francis in Bioanalysis
- Vol. 17 (11) , 707-723
Quantitation of BCAA and BCKA in plasma and patient-centric dried blood microsamples in a clinical setting
This study assessed the agreement and bias of three dried blood patient-centric microsampling (PCS) devices (paper DBS, Mitra, and Tasso-M20) for the quantitation of branched chain amino acids (BCAAs) and ketoacids (BCKAs) compared to venous plasma samples. Concentrations of BCAAs and BCKAs were measured in samples from generally healthy participants with a validated assay for venous plasma adapted for use with dried blood from the PCS devices. Participants were also asked to respond to a device usability questionnaire about their experience with the devices. The correlations between BCAA/BCKA concentration values in PCS devices vs venipuncture samples were strong to excellent for all six analytes, across all three PCS devices. The surrogate analyte approach facilitated method transfer from plasma to dried blood microsampling devices. Overall, participants reported that they enjoyed using the devices compared to traditional venipuncture and would be willing to use them again, on their own at-home. These study results demonstrate the feasibility of quantitating BCAAs and BCKAs reliably with PCS devices, with high acceptability from study participants.
- 3 June 2025
- Published by Taylor & Francis in Bioanalysis
- Vol. 17 (11) , 707-723
Open AccessQuantitation of BCAA and BCKA in plasma and patient-centric dried blood microsamples in a clinical setting
This study assessed the agreement and bias of three dried blood patient-centric microsampling (PCS) devices (paper DBS, Mitra, and Tasso-M20) for the quantitation of branched chain amino acids (BCAAs) and ketoacids (BCKAs) compared to venous plasma samples. Concentrations of BCAAs and BCKAs were measured in samples from generally healthy participants with a validated assay for venous plasma adapted for use with dried blood from the PCS devices. Participants were also asked to respond to a device usability questionnaire about their experience with the devices. The correlations between BCAA/BCKA concentration values in PCS devices vs venipuncture samples were strong to excellent for all six analytes, across all three PCS devices. The surrogate analyte approach facilitated method transfer from plasma to dried blood microsampling devices. Overall, participants reported that they enjoyed using the devices compared to traditional venipuncture and would be willing to use them again, on their own at-home. These study results demonstrate the feasibility of quantitating BCAAs and BCKAs reliably with PCS devices, with high acceptability from study participants.
- Open Access
- 1 June 2021
- Published by Elsevier in Molecular Metabolism
- Vol. 48, 101196
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction
- 1 June 2021
- Published by Elsevier in Molecular Metabolism
- Vol. 48, 101196
Open AccessPharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction